Printer Friendly Printed from http://www.researchandmarkets.com/reports/1079 CNS Year in Review: 2001 Description: This Market Brief sets out the sales figures of the leading CNS drugs for 2001, together with the leading events, be they clinical trial results, product launches, patent expiries or court room battles which have helped to shape the market throughout the year. The major CNS disease markets are examined, namely Alzheimer’s disease, anticonvulsants, antidepressants, antipsychotics, migraine, multiple sclerosis, pain, and Parkinson’s disease. This brief paints a preliminary picture of the 2001 CNS market before the full yearly breakdowns have become available. Furthermore, it also provides a brief overview of the current trends in the CNS market and how individual markets may develop. The sales figures set out in this report are obtained from one of three sources. Priority was given to published 2001 results, however most of the figures presented are derived from primary research regarding quarterly sales, which were then projected to give a full year figure. However, in some cases it was not possible to obtain such figures. In these cases, the most up to date forecasts from Datamonitor’s reports were taken. Contents: TABLE OF CONTENTS INTRODUCTION 2001 global CNS market ALZHEIMER’S DISEASE MARKET 2001 global market 2001 product highlights Aricept: defending its position Reminyl: establishing itself as a major player ANTICONVULSANTS MARKET 2001 global market 2001 product highlights Neurontin: driving its revenue growth through neuropathic pain and other novel markets Lamictal: attempting to keep pace with Neurontin ANTIDEPRESSANT MARKET 2001 global market 2001 product highlights Prozac: market collapse following US generic competition Prozac Weekly/Remeron SolTab: novel formulations underpin strategies to prolong product lifecycles Paxil: further indications drive growth but generic substitution threatens future Zoloft: gearing up for additional licenses to challenge Paxil ANTIPSYCHOTIC MARKET 2001 global market 2001 product highlights Zyprexa: further growth expanded its dominant position Seroquel: raising its game Risperdal: innovating its class through product reformulation Geodon: Pfizer finally enters the US market MIGRAINE MARKET 2001 global market 2001 product highlights Imigran: development of innovative marketing strategies Zomig: driving sales through reformulation MULTIPLE SCLEROSIS MARKET 2001 global market 2001 product highlights Avonex: pivotal trials driving revenue growth Betaseron: attempting to prove US regulators wrong PAIN MARKET 2001 global market 2001 product highlights Celebrex: relying on DTC and clinical data to stimulate revenues following cardiovascular fiasco Vioxx: undermined by clincial trial data PARKINSON’S DISEASE MARKET 2001 global market 2001 product highlights Comtan: driven by North American revenues ReQuip: clinical trial data expanding patients and BIBLIOGRAPHY References Websites DATAMONITOR HEALTHCARE Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1079 Order by Fax - using the order form below Order By Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Printed 30/08/2008 14:03:30 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com Order information Please verify that the product information is correct and select the format you require. Product Name: CNS Year in Review: 2001 Web Address: http://www.researchandmarkets.com/reports/1079 Office Code: OCHGMKRTUOY Report formats Please enter the quantity of the report format you require. Format Quantity Price Hard Copy €1,669.00 + EUR€ 50.00 Shipping/Handling * Electronic €1,605.00 Electronic - Site License €1,605.00 * Shipping/Handling is only charged once per order. Contact information Please enter all the information below in BLOCK CAPITALS. First Name:   Last Name:   Email Address: Job Title: Organisation: Address: City: Postal/Zip Code: Country: Phone Number: Fax Number: Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World Page 2 of 2 Printed 30/08/2008 14:03:30 Payment information Please indicate the payment method you would like to use by selecting the appropriate box.  Pay by Credit Card: American Express Diners Club Master Card Visa Cardholder Name: Expiry Date: / Card Number: CVV Security Code: Issue Date: /   (Diners Club only)  Pay by Check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.  Pay by Wire Transfer: Please transfer funds to: Account number: 83313083 Sort code: 98-53-30 Swift code: ULSBIE2D IBAN number: IE78ULSB98533083313083 Bank Address: Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World